ACM
IART icon

Aster Capital Management’s Integra LifeSciences IART Stock Holding History

Aster Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3K Buy
+742
New +$10.4K ﹤0.01% 642
2025
Q3 		– Sell
-1,797
Closed -$22K – 1148
2025
Q2 		$22K Buy
+1,797
New +$26.1K 0.01% 695
2024
Q4 		– Sell
-605
Closed -$11K – 1293
2024
Q3 		$11K Buy
+605
New +$14K ﹤0.01% 786

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Aster Capital Management's IART Position: Q2 2026 in Review

Aster Capital Management opened a new position in Integra LifeSciences (IART) in Q2 2026: 742 shares worth $13.3K. The stake represents ﹤0.01% of the portfolio and ranks #642 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in IART as recently as Q2 2025.

Aster Capital Management first reported a position in IART in Q3 2024 and has held it in 3 quarters since. The position peaked at $22K in Q2 2025. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Aster Capital Management held 742 shares of Integra LifeSciences worth $13.3K as of Q2 2026.
  • Integra LifeSciences was a new Aster Capital Management position in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Aster Capital Management's portfolio in Q2 2026, its #642 holding.
  • Aster Capital Management first reported a position in Integra LifeSciences in Q3 2024 and has held it in 3 quarters since.
  • Aster Capital Management's Integra LifeSciences position peaked at $22K in Q2 2025.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.